AzTrials
AzTrials

TBI (Traumatic Brain Injury)KAOUENNNCT06024122

Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study

An observational study of TBI (Traumatic Brain Injury), run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Concussions (also known as mild traumatic brain injury) are common in young children. In some children, they can lead to short- and long-term difficulties. However, our knowledge of the exact consequences of injuries on young children's brains and behavior is limited. Read more about this study

Who is it for?
Ages 36 to 71 months
Conditions the study is for
TBI (Traumatic Brain Injury)
What is being tested?
IRM exam
How many people
60 participants
Where
1 siteFrance
Study dates
3 Jul 2024to Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 36 to 71 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children aged between 36 months (3 years) and 71 months and 31 days (5 years; before their 6th birthday) with mTBI. Children aged between 36 months (3 years) and 71 months and 31 days (5 years; before their 6th birthday) with orthopaedic injury (simple fracture, sprain, contusion or unspecified trauma to a limb (mild))

Who may be able to join

  • Patient group with mild traumatic brain injury (mTBI) :
  • Children aged between 36 months (3 years) and 71 months and 31 days (5 years; before their 6th birthday)
  • Presentation to the emergency department within 48 hours post-injury
  • Documented, unintentional traumatic event (e.g. blow, fall, etc.) resulting in non-penetrating head injury
  • Diagnosis of mTBI (World Health Organization (WHO) paediatric diagnostic criteria)
  • Control group with orthopaedic injury:
Show all 10Show fewer
  • Children aged between 36 months (3 years) and 71 months and 31 days (5 years; before their 6th birthday)
  • Presentation to the emergency department within 48 hours post-injury
  • Documented, unintentional traumatic event (e.g. blow, fall, etc.) resulting in trauma to an upper or lower limb
  • Diagnosis of simple fracture, sprain, contusion or unspecified trauma to a limb (mild).

Who cannot join

  • Diagnosis of previous TBI (any severity, any age)
  • Intentional injury,
  • Administration of sedative drugs that can alter brain function
  • Complications following injury
  • MRI contraindication,
  • Parent non-fluent in French,
Show all 9Show fewer
  • Prematurity,
  • Diagnosis of a severe neurological, developmental, or psychiatric disorder
  • Children in foster care at the time of recruitment

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site, 1 recruiting
  • Unité des urgences médicochirurgicales CHU Rennes

    Rennes, 35200

    Véronique Chasle, MD, +33 2 99 26 67 58, veronique.chasle@chu-rennes.fr

    Recruiting

Other trials in France

About this study

Concussions (also known as mild traumatic brain injury) are common in young children. In some children, they can lead to short- and long-term difficulties. However, our knowledge of the exact consequences of injuries on young children's brains and behavior is limited. These consequences may be different in children under 6, as their brains are fragile and undergoing significant developmental changes.

The aim of this study is to determine the extent to which a concussion sustained before the age of 6 years is associated with changes in young children's brain structure, function and behaviours, using a brain imaging.

In this study, the results of a group of 30 children with a concussion will be compared to those of 30 children of the same age with an orthopaedic injury to the upper or lower limbs.

Being tested
IRM exam
Medical subject headings
Brain Injuries, Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IRM examOther

    A non-sedated MRI scan will be performed to assess the structure and function of the children's brains

Study groups in NCT06024122
Study groupRoleWhat they receive
Patients with a mTBIChildren with a mTBI aged 3 to 5 years (i.e., up to 71 months and 31 days, i.e., before the 6th birthday) recruited from the paediatric emergency department of Rennes University Hospital.
Receives: Other: IRM exam
Control with an orthopaedic injuryChildren with an orthopaedic injury aged 3 to 5 years (i.e., up to 71 months and 31 days, i.e., before the 6th birthday) recruited from the paediatric emergency department of Rennes University Hospital.
Receives: Other: IRM exam

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Persistent brain structure alterations

    Quantitative assessment of the brain morphometry extracted from T1-w MRI sequence

    Measured: 3 months post-injury

Secondary outcomes (5)
  1. Persistent brain lesions - Volume

    Volume of brain lesions measured with susceptibility MRI

    Measured: 3 months post-injury

  2. Persistent brain lesions - Number

    Number brain lesions measured with susceptibility MRI

    Measured: 3 months post-injury

  3. Cerebral blood flow alteration

    Cerebral blood flow quantified by arterial spin labelling perfusion MRI (ASL)

    Measured: 3 months post-injury

  4. Functional integrity of brain networks

    Functional connectivity (i.e., correlation between the activation of brain regions) measured by resting-state functional MRI

    Measured: 3 months post-injury

  5. Structural integrity of brain networks

    White matter micro-structure measured by diffusion MRI

    Measured: 3 months post-injury

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Sep 2023
  2. Study start3 Jul 2024
  3. Primary completionOct 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06024122
Sponsor's protocol ID
C22-48
Other IDs
2022-A02619-34
Acronym
KAOUENN
Status last verified
Mar 2026
First submitted
7 Jul 2023
Last updated
5 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of TBI (Traumatic Brain Injury), run by Institut National de la Santé Et de la Recherche Médicale, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fanny DÉGEILH, PhD (+33 2 99 84 71 63, fanny.degeilh@inserm.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Persistent brain structure alterations (time frame: 3 months post-injury). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in